Skip to main content

MoneyWorks4Me

Lupin informs about compliances-certificate

05 Apr 2024 Evaluate
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, Lupin has forwarded a copy of the Certificate received from Link Intime (India), the Registrar and Share Transfer Agent of the Company, for the quarter ended at March 31, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..